UK life sciences plan falls short, says ABPI
The ABPI is warning that the core ambition of the government's new life sciences strategy will not be realised unless it makes a real commitment to invest more in new medicines.
Read the full articleYou might also wanna read
UK Life Sciences Must Move From Innovation Pilots to National Adoption
The UK is not short of innovation. The challenge is building the national systems, funding routes and procurement models needed to turn prom
Life sciences pulled in over £3bn since since sector plan launched
The UK life sciences sector has attracted more than £3bn in new public-private investment in the past 12 months, marking the first year of a
UK parliamentary committee warns Britain lacks coherent strategy for AI and tech sovereignty
Committee says Anthropic's brief US export ban shows UK can't even trust its allies to keep the AI lights on
theregister.com·3d ago
NHS Fast-tracks Life-changing Medicines in Landmark UK-US Access Overhaul
A new series of NHS pilot schemes could give patients access to innovative medicines months earlier while supporting investment in the UK's
Rakesh Uppal comments on London Life Sciences Strategy
Writing for Healthcare Today, Rakesh Uppal, chief executive of Barts Life Sciences, says that an ambitious life sciences strategy for London
to the point: Healthcare & Life Sciences Q2/2026
......
Comments
Sign in to join the conversation.
No comments yet. Be the first.